Partial Cystectomy With Pelvic Lymph Node Dissection for Patients With Nonmetastatic Stage pT2-T3 Urothelial Carcinoma of Urinary Bladder: Temporal Trends and Survival Outcomes

Francesco A. Mistretta, Sarah Jeanne Cyr, Stefano Luzzago, Elio Mazzone, Sophie Knipper, Carlotta Palumbo, Zhe Tian, Sebastiano Nazzani, Fred Saad, Emanuele Montanari, Derya Tilki, Alberto Briganti, Shahrokh F. Shariat, Ottavio de Cobelli, Pierre I. Karakiewicz

Research output: Contribution to journalArticlepeer-review

Abstract

Using data from the Surveillance, Epidemiology, and End Results database (2004-2015), 11,429 cases of nonmetastatic stage pT2-T3 urothelial carcinoma of the urinary bladder treated with either partial cystectomy (PC) or radical cystectomy (RC) were evaluated. No statistically significant differences in cancer-specific or other-cause mortality between the PC and RC groups was identified. Within the PC group, pelvic lymph node dissection had been omitted 50% of the time despite its association with lower cancer-specific mortality rates.

Original languageEnglish
JournalClinical Genitourinary Cancer
DOIs
Publication statusAccepted/In press - Jan 1 2020

Keywords

  • Cystectomy
  • Lymph node excision
  • Mortality
  • SEER program
  • Urinary bladder neoplasms

ASJC Scopus subject areas

  • Oncology
  • Urology

Fingerprint

Dive into the research topics of 'Partial Cystectomy With Pelvic Lymph Node Dissection for Patients With Nonmetastatic Stage pT2-T3 Urothelial Carcinoma of Urinary Bladder: Temporal Trends and Survival Outcomes'. Together they form a unique fingerprint.

Cite this